We are live on ! Find out more
PAHC icon

Phibro Animal Health

155 hedge funds and large institutions have $492M invested in Phibro Animal Health in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

11% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 53

0% more funds holding

Funds holding: 155155 (0)

5% less capital invested

Capital invested by funds: $517M → $492M (-$24.4M)

1.1% less ownership

Funds ownership: 102.4%101.3% (-1.1%)

Holders
155
Holders Change
Holders Change %
0%
% of All Funds
3.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
59
Reduced
53
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SDIC
26
South Dakota Investment Council
South Dakota
$3.98M +$220K +9,005 +6%
PPA
27
Parametric Portfolio Associates
Washington
$3.66M +$1.47M +60,189 +66%
Invesco
28
Invesco
Georgia
$3.48M -$230K -9,414 -6%
Bank of America
29
Bank of America
North Carolina
$3.33M +$417K +17,058 +14%
Ameriprise
30
Ameriprise
Minnesota
$3.11M +$175K +7,165 +6%
Charles Schwab
31
Charles Schwab
California
$3.05M +$64.2K +2,627 +2%
AQR Capital Management
32
AQR Capital Management
Connecticut
$3M -$98.3K -4,024 -3%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$2.98M +$1.09M +44,621 +57%
Victory Capital Management
34
Victory Capital Management
Texas
$2.79M +$1.51M +61,705 +114%
JP Morgan Chase
35
JP Morgan Chase
New York
$2.79M +$476K +19,475 +20%
Man Group
36
Man Group
United Kingdom
$2.69M -$1.45M -59,282 -35%
MSL
37
Mackay Shields LLC
New York
$2.36M -$973K -39,800 -29%
BCC
38
Bridge City Capital
Oregon
$2.1M +$245K +10,019 +13%
WG
39
Winton Group
United Kingdom
$1.98M -$119K -4,851 -6%
SBH
40
Segall Bryant & Hamill
Illinois
$1.89M +$531K +21,733 +39%
Citadel Advisors
41
Citadel Advisors
Florida
$1.87M -$1.63M -66,715 -46%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$1.86M -$34.2K -1,400 -2%
Massachusetts Financial Services
43
Massachusetts Financial Services
Massachusetts
$1.79M +$286K +11,693 +19%
QI
44
QS Investors
New York
$1.75M -$167K -6,848 -9%
Bessemer Group
45
Bessemer Group
New Jersey
$1.66M +$362K +14,800 +27%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.62M +$28.9K +1,182 +2%
Morgan Stanley
47
Morgan Stanley
New York
$1.43M -$11.9M -487,092 -89%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$1.38M +$142K +5,794 +11%
DCM
49
Dupont Capital Management
Delaware
$1.37M -$234K -9,581 -14%
Fidelity Investments
50
Fidelity Investments
Massachusetts
$1.28M -$1.98M -81,099 -60%

PAHC Hedge Fund Activity: Q1 2020 in Review

155 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2020, worth a combined $492M — down 4.7% from $517M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PAHC positions and 16 closed out — a net gain of 2 holders — while 59 added to existing stakes and 53 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $24.9M. The largest seller was Morgan Stanley, cutting an estimated $11.9M.

  • 155 institutional investors held Phibro Animal Health (PAHC) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $492M of Phibro Animal Health stock for Q1 2020, down 4.7% quarter-over-quarter.
  • 18 funds opened new Phibro Animal Health positions in Q1 2020 and 16 closed out, a net change of +2 holders.
  • The largest Phibro Animal Health buyer in Q1 2020 was Principal Financial Group, an estimated $24.9M added.
  • The largest Phibro Animal Health seller in Q1 2020 was Morgan Stanley, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2020.